1-7 of 7
Shigeru Tomoyasu, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of CD20-Mediated Signals in Refractory Diffuse Large B-Cell Lymphoma Cells.

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, Hidetoshi Nakashima, MD, Hirotsugu Ariizumi, MD, Takashi Maeda, MD, Bungo Saito, MD, Kouji Yanagisawa, MD, Shigeru Tomoyasu, MD
Journal: Blood
Blood (2012) 120 (21): 2684.
https://doi.org/10.1182/blood.V120.21.2684.2684
Published: 2012
Journal Articles

Comprehensive Profiling of Somatic Mutations Which Define Primary Disease and Relapse in Various Acute Leukemia Subtypes

Vikas Madan, PhD, Wen-Wen Chien, PhD, Ding Ling Wen, PhD, Manoj Garg, PhD, Norimichi Hattori, Sun Qiaoyang, PhD, Henry Yang, PhD, Yasunobu Nagata, MD, Kenichi Yoshida, MD, Masashi Sanada, MD, Yusuke Okuno, MD, PhD, Tamara Alpermann, Ezhilarasi Chendamarai, Saravanan Ganesan, MSc, Daniel Nowak, MD, Tsuyoshi Nakamaki, MD, Norihiko Kawamata, Takayuki Ikezoe, Shirley, Kow Yin Kham, Jairo Matthews, Liu Lizhen, Meng Xuan, Lim Su Lin, Olga Blau, MD, PhD, Steven M. Kornblau, MD, PhD, Michael Andreeff, MD, PhD, Shigeru Tomoyasu, MD, Wolf-Karsten Hofmann, Allen Yeoh, Seishi Ogawa, MD, PhD, Vikram Mathews, Torsten Haferlach, MD, Lee-Yung Shih, MD, Phillip Koeffler, MD
Journal: Blood
Blood (2012) 120 (21): 783.
https://doi.org/10.1182/blood.V120.21.783.783
Published: 2012
Journal Articles

Inhibition of Phosphatidylinositol 3-Kinase Is Effective to Suppress the Growth of CD20-Negative Refractory Diffuse Large B-Cell Lymphoma Cells

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, MD, Hidetoshi Nakashima, MD, Hirotsugu Ariizumi, MD, Takashi Maeda, MD, Bungo Saito, MD, Kouji Yanagisawa, MD, Shigeru Tomoyasu, MD, Eisuke Shiozawa, MD, Toshiko Yamochi-Onizuka, MD, Hidekazu Ota, MD
Journal: Blood
Blood (2011) 118 (21): 2421.
https://doi.org/10.1182/blood.V118.21.2421.2421
Published: 2011
Journal Articles

Activated c-Jun N-Terminal Kinase Is a Therapeutic Target in Advanced Stage ALK-Negative Anaplastic Large Cell Lymphoma.

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, MD, Toshiko Yamochi-Onizuka, MD, Hidekazu Ota, MD, Shigeru Tomoyasu, MD
Journal: Blood
Blood (2007) 110 (11): 1391.
https://doi.org/10.1182/blood.V110.11.1391.1391
Published: 2007
Journal Articles

Increased Expression of Cyclin A1 mRNA Is a Novel Adverse Prognostic Indicator for Acute Promyelocytic Leukemia in Differentiation Therapy by All- Trans Retinoic Acid.

Tsuyoshi Nakamaki, MD, Hidetoshi Nakashima, MD, Masamichi Hattori, MD, Takako Usui, MD, Mayumi Honma, MD, Daisuke Adachi, MD, Bungo Saito, MD, Shigeru Tomoyasu, MD
Journal: Blood
Blood (2006) 108 (11): 2344.
https://doi.org/10.1182/blood.V108.11.2344.2344
Published: 2006
Journal Articles

Altered Expressions of CD30, c-Jun N-Terminal Kinase, NF-κB and JunB Are Involved in Disease Progression in CD30-Positive Anaplastic Large Cell Lymphoma.

Tsuyoshi Nakamaki, MD, Hidetoshi Nakashima, MD, Masamichi Hattori, MD, Takako Usui, MD, Takashi Maeda, MD, Kunihiko Fukuchi, MD, Shigeru Tomoyasu, MD
Journal: Blood
Blood (2005) 106 (11): 2827.
https://doi.org/10.1182/blood.V106.11.2827.2827
Published: 2005
Journal Articles

Analysis of Factors Involved in Malignant Progression of Anaplastic Large Cell Lymphoma Kinase (ALK) -Negative Anaplastic Large Cell Lymphoma.

Tsuyoshi Nakamaki, MD, Takashi Maeda, MD, Hidetoshi Nakashima, MD, Masamichi Hattori, MD, Takako Usui, MD, Shigeru Tomoyasu, MD, Yoshio Honma, PhD
Journal: Blood
Blood (2004) 104 (11): 3272.
https://doi.org/10.1182/blood.V104.11.3272.3272
Published: 2004